Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malaria.

Brian M Greenwood1, Kalifa Bojang, Christopher J M Whitty

  • 1Gates Malaria Partnership, Department of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London WC1B 3DP, UK. brian.greenwood@lshtm.ac.uk

Lancet (London, England)
|April 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The burden of malaria-attributable maternal anaemia and the impact of preventive treatment across sub-Saharan Africa.

Nature health·2026
Same author

The importance of strengthening iNGO research and supporting evidence uptake.

International health·2025
Same author

BactiVac, the Bacterial Vaccines Network.

Vaccine·2025
Same author

Climate change, malaria and neglected tropical diseases: a scoping review.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2024
Same author

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.

Lancet (London, England)·2024
Same author

Post-discharge malaria chemoprevention in children admitted with severe anaemia in malaria-endemic settings in Africa: a systematic review and individual patient data meta-analysis of randomised controlled trials.

The Lancet. Global health·2023
Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026
Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
See all related articles

Malaria remains a major global health threat, causing over a million deaths annually. New prevention and treatment strategies, including improved bed nets and promising vaccines, are crucial for combating this parasitic infection.

Area of Science:

  • Global Health
  • Infectious Diseases
  • Parasitology

Background:

  • Malaria is a leading cause of mortality, particularly in developing nations.
  • It is the most significant parasitic infection affecting humans worldwide.
  • Over one million deaths are attributed to malaria each year, highlighting its critical impact.

Purpose of the Study:

  • To review current and emerging strategies for malaria prevention and treatment.
  • To assess the potential of new interventions in combating malaria.
  • To identify challenges and opportunities in malaria control efforts.

Main Methods:

  • Review of existing malaria control methods, including insecticide-treated bed nets.
  • Analysis of novel drug development pipelines for malaria treatment.

Related Experiment Videos

  • Evaluation of promising malaria vaccine candidates in clinical trials.

    • Main Results:

    • Insecticide-treated bed nets, especially long-lasting formulations, are effective prevention tools.
    • New antimalarial drugs are in development for combination therapies to manage resistance.
    • One malaria vaccine (RTS,S/AS02) shows promise, with further trials planned; widespread availability is anticipated in over a decade.

    Conclusions:

    • Enhanced financial and labor resources are needed to optimize existing malaria control methods.
    • Sustainable implementation of new, potentially costly, malaria treatments requires careful planning.
    • While promising, a widely available malaria vaccine is still at least 10 years away, necessitating continued focus on current prevention and treatment strategies.